|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income: | ||
| Other income | ||
| Net loss | ||
| Net loss per share—basic and diluted | ||
| Weighted-average common stock outstanding—basic and diluted | ||
| Net loss per share - basic | ||
| Net loss per share - diluted | ||
| Weighted-average common stock outstanding - basic | ||
| Weighted-average common stock outstanding - diluted |
Loading...
